FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a monoclonal antibody, its fragment, as well as a pharmaceutical composition containing them. A hybridome for producing the above-mentioned monoclonal antibody or antigen-binding fragment is also disclosed
EFFECT: invention makes it possible to effectively perform functional inhibition of the immunosuppressive functions of the pathogen, where the specified pathogen is Helicobacter pylori.
12 cl, 16 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES DIRECTED TO CD127 | 2015 |
|
RU2734076C2 |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEINE | 2012 |
|
RU2743738C2 |
| ANTIBODY AGAINST TNFR2 AND ITS APPLICATION | 2020 |
|
RU2793165C1 |
| ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
| ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION | 2018 |
|
RU2745451C1 |
| ANTI-GARP ANTIBODY | 2016 |
|
RU2769379C2 |
| ANTI-HLA-A2 ANTIBODIES AND THEIR APPLICATION METHODS | 2018 |
|
RU2782276C2 |
| BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION | 2019 |
|
RU2764740C1 |
| ANTIBODIES TO CERAMIDE | 2015 |
|
RU2717651C2 |
| ANTI-TNFRSF25 ANTIBODIES | 2017 |
|
RU2746314C2 |
